SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Is the Deadly Kissing Bug Disease the New HIV/AIDS? Baylor College of Medicine Reveals
June 1, 2012
 · 
1 min read
Lone Star Bio
Is There a “Healthy” Obesity Gene? Texas A&M University System Study
June 1, 2012
 · 
1 min read
Lone Star Bio
Mechanism That Maintains Stem Cells Readiness Identified, UT Southwestern Medical Center Study
June 1, 2012
 · 
1 min read
Lone Star Bio
50-Year Cholera Mystery Solved, University of Texas Study
May 30, 2012
 · 
1 min read
Lone Star Bio
Skp2 Activates Cancer-Promoting, Glucose-Processing Akt, MD Anderson Study
May 29, 2012
 · 
1 min read
Lone Star Bio
WWII Chemical Exposure May Pass Down Disease, University of Texas Study
May 24, 2012
 · 
1 min read
Lone Star Bio
Advanced Genetic Screening Method May Speed Vaccine Development, University of Texas Study
May 11, 2012
 · 
1 min read
Lone Star Bio
Belly Lift Device Helps Obese Patients Breathe, Rice University Study
May 10, 2012
 · 
1 min read
Lone Star Bio
Under-Skin Device Powers Tiny Heart Pump, Rice University Study
May 7, 2012
 · 
1 min read
Lone Star Bio
Breastfeeding Keeps Infants’ Guts Healthy, Texas A&M University Study
April 30, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Load More